Generate Biomedicines, Inc. (GENB)

15.19 -0.80 (-5.00%) USD  |  NASDAQ  |  Sep 25, 14:52
More

Generate Biomedicines Cash from Operations (TTM) : -240.26M for June 30, 2026

Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for GENB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 -240.26M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Twist Bioscience Corp. -53.07M
Intellia Therapeutics, Inc. -346.64M
Prime Medicine, Inc. -156.05M
Moderna, Inc. -1.073B
Beam Therapeutics, Inc. -359.38M